Letter: Treatment of leishmaniasis with a nitrofurfurylidene derivative (Bay 2502).
D003499:Cyclic S-Oxides / Q000627:therapeutic use; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy*; D009581:Nitrofurans / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*; D014349:Trypanosoma cruzi; D014352:Trypanosomiasis / Q000188:drug therapy*
D003499:Cyclic S-Oxides; D009581:Nitrofurans; D013843:Thiazines